Last reviewed · How we verify
NCT06298292: ZeroMinisMR
Acceptability/Tolerance of Protein Substitutes in Tablet Form for the Dietary Management of Rare Aminoacidopathies
trial testing Zero minis (range of protein substitutes in tablet form) in Tyrosinemia, Type I in 15 participants. Not yet recruiting.
31 March 2026
Quick facts
| Lead sponsor | metaX Institut fuer Diatetik GmbH |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 15 |
| Start date | 1 April 2024 |
| Primary completion | 31 March 2026 |
| Estimated completion | 30 June 2026 |
Drugs / interventions tested
- Zero minis (range of protein substitutes in tablet form)
Conditions studied
- Tyrosinemia, Type I — all drugs for Tyrosinemia, Type I →
- Tyrosinemia, Type II — all drugs for Tyrosinemia, Type II →
- Tyrosinemia, Type III — all drugs for Tyrosinemia, Type III →
- Alkaptonuria — all drugs for Alkaptonuria →
Sponsor
metaX Institut fuer Diatetik GmbH
Who can join
Adults 7 to 18, any sex, with Tyrosinemia, Type I or Tyrosinemia, Type II. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this prospective, observational study is to evaluate the tolerability and acceptability of Zero minis, a range of protein substitute tablets for use in the dietary management of children with either TYROSINAEMIA Type I, II, III or ALKAPTONURIA, HOMOCYSTINURIA, or MAPLE SYRUP URINE DISEASE (MSUD) over the age of 7 years.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06298292
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other metaX Institut fuer Diatetik GmbH trials
Trials by the same sponsor.
- NCT04375592 — Acceptability and Tolerance of a Ready-to-use Protein Substitute in Tablet Form for the Dietary Management of Phenylketo · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06298292 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by metaX Institut fuer Diatetik GmbH
- Last refreshed: 7 March 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06298292.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing